Open Beta
MetriLume

US marketsTDOC

SEC-sourced researchBeta

TDOC

Teladoc Health, Inc.

Company comparison ↗

Data passport

CIK
0001477449
Exchange
NYSE
Business activity
— · SIC 8011
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 2,602,415,000.0000 USD; December 2024: 2,569,574,000.0000 USD; December 2025: 2,529,977,000.0000 USD2.6B USD0 USD0December 2023December 2024December 2025
TDOC · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20232,602,415,000.0000Feb 26, 2026
December 20242,569,574,000.0000Feb 26, 2026
December 20252,529,977,000.0000Feb 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20252,529,977,000.0000-200,322,000.0000294,357,000.00002,858,300,000.00001,472,594,000.0000Feb 26, 2026
December 20242,569,574,000.0000-1,001,245,000.0000293,680,000.00003,516,524,000.00002,025,445,000.0000Feb 26, 2026
December 20232,602,415,000.0000-220,368,000.0000350,021,000.0000——Feb 26, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$2.53BDecember 2025Feb 26, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$2.57BDecember 2024Feb 26, 202610-K
Net incomeNetIncomeLoss-$200.32MDecember 2025Feb 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$294.36MDecember 2025Feb 26, 202610-K
Total assetsAssets$2.86BDecember 2025Feb 26, 202610-K
Total liabilitiesLiabilities$1.47BDecember 2025Feb 26, 202610-K

New filings

Explore methodology ↗